InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: SeanVan post# 509

Friday, 12/29/2023 9:38:16 AM

Friday, December 29, 2023 9:38:16 AM

Post# of 547
I don't agree. My friends, employees, and I had direct experience with Anatabloc, a product of William's Star Scientific. The anatabine-citrate molecule was the real thing. The benefits were remarkable. People homebound with Crohn's disease were set free.

Now, there is evidence that the isomyosmine molecule, MYMD-1, is an improvement on anatabine-citrate.

The article linked should be treated with suspicion as a possible "hit piece". There were political currents involving Bob McDonnell's race for governor of Virginia. Williams got swept up in those currents and a letter was issued by the FDA (trust them? no) that destroyed his company and injured McDonnell.

The molecule being developed by Williams and his collaborators at Johns Hopkins is both a threat and an opportunity for major pharma companies currently earning large revenues from the sale of biologics.

MYMD-1 does everything the leading biologics (Enbrel, Humira) do, but better and without the serious side effects. They are biological sledge hammers, MYMD-1 is a jewelers hammer.

Ray Blanco's assessment is correct.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News